Currency converter
12 Jun 2025 21:10
(0%)
Closing price, the previous day.
Opening price.
The highest price over the last trading day.
The lowest price over the last trading day
Price range high in the last week
Price range low in the last week
Dynavax Technologies Corporation is a biopharmaceutical company whose core business is the development and production of vaccines.
The company’s main product is a hepatitis B drug. The company also produces vaccines against coronavirus, influenza, plague, and other infectious diseases.
In addition, the company is mainly focused on the production of adjuvants. These substances help vaccines to be better absorbed by the body.
Currently, Dynavax has a market capitalization of $1.37 billion. Last year, the company posted revenues of $438.24 million and a net income of $76.71 million.
Dynavax shares have been trading on the NASDAQ exchange under the DVAX ticker since 2004. The initial price per share stood at $7.50.
Currently, the company’s shares are trading between $10 and $12. During the year, the share price was hovering between $7 and $22. At the same time, the company does not pay dividends to its shareholders.
What to pay attention to when trading the company’s shares:
Training video
Your IP address shows that you are currently located in the USA. If you are a resident of the United States, you are prohibited from using the services of InstaFintech Group including online trading, online transfers, deposit/withdrawal of funds, etc.
If you think you are seeing this message by mistake and your location is not the US, kindly proceed to the website. Otherwise, you must leave the website in order to comply with government restrictions.
Why does your IP address show your location as the USA?
Please confirm whether you are a US resident or not by clicking the relevant button below. If you choose the wrong option, being a US resident, you will not be able to open an account with InstaTrade anyway.
We are sorry for any inconvenience caused by this message.